206 related articles for article (PubMed ID: 34112167)
1. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3.
Chen W; Song J; Liu S; Tang B; Shen L; Zhu J; Fang S; Wu F; Zheng L; Qiu R; Chen C; Gao Y; Tu J; Zhao Z; Ji J
J Biomed Sci; 2021 Jun; 28(1):44. PubMed ID: 34112167
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
3. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.
Schlisio S; Kenchappa RS; Vredeveld LC; George RE; Stewart R; Greulich H; Shahriari K; Nguyen NV; Pigny P; Dahia PL; Pomeroy SL; Maris JM; Look AT; Meyerson M; Peeper DS; Carter BD; Kaelin WG
Genes Dev; 2008 Apr; 22(7):884-93. PubMed ID: 18334619
[TBL] [Abstract][Full Text] [Related]
4. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
[TBL] [Abstract][Full Text] [Related]
5. Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid.
Chen X; Zhang X; Cai H; Yang W; Lei H; Xu H; Wang W; Zhu Q; Kang J; Yin T; Gu W; Wu YL
Cancer Lett; 2020 Jan; 469():277-286. PubMed ID: 31605775
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
Lin L; Cai J
J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
[TBL] [Abstract][Full Text] [Related]
7. Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase.
Zheng X; Zhai B; Koivunen P; Shin SJ; Lu G; Liu J; Geisen C; Chakraborty AA; Moslehi JJ; Smalley DM; Wei X; Chen X; Chen Z; Beres JM; Zhang J; Tsao JL; Brenner MC; Zhang Y; Fan C; DePinho RA; Paik J; Gygi SP; Kaelin WG; Zhang Q
Genes Dev; 2014 Jul; 28(13):1429-44. PubMed ID: 24990963
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
Lu Q; Lu D; Shao ZM; Li DQ
Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
[TBL] [Abstract][Full Text] [Related]
9. Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.
Chen X; Lu D; Gao J; Zhu H; Zhou Y; Gao D; Zhou H
J Proteome Res; 2019 Jun; 18(6):2654-2665. PubMed ID: 31059266
[TBL] [Abstract][Full Text] [Related]
10. Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.
Bianchetti E; Bates SJ; Carroll SL; Siegelin MD; Roth KA
Sci Rep; 2018 Nov; 8(1):17390. PubMed ID: 30478285
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
Li H; Zheng B
Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
[TBL] [Abstract][Full Text] [Related]
12. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
[TBL] [Abstract][Full Text] [Related]
13. Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.
Izrailit J; Jaiswal A; Zheng W; Moran MF; Reedijk M
Oncogene; 2017 Feb; 36(8):1048-1057. PubMed ID: 27593927
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer.
Liu L; Yao D; Zhang P; Ding W; Zhang X; Zhang C; Gong S; Zhang Y; Wang J; Sun T; Ren Z
Oncol Rep; 2017 Dec; 38(6):3531-3537. PubMed ID: 29130109
[TBL] [Abstract][Full Text] [Related]
15. Catalytic-independent inhibition of cIAP1-mediated RIP1 ubiquitination by EGLN3.
Fu J
Cell Signal; 2016 Feb; 28(2):72-80. PubMed ID: 26612615
[TBL] [Abstract][Full Text] [Related]
16. PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359.
Rodriguez J; Herrero A; Li S; Rauch N; Quintanilla A; Wynne K; Krstic A; Acosta JC; Taylor C; Schlisio S; von Kriegsheim A
Cell Rep; 2018 Jul; 24(5):1316-1329. PubMed ID: 30067985
[TBL] [Abstract][Full Text] [Related]
17. Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
Sulkshane P; Pawar SN; Waghole R; Pawar SS; Rajput P; Uthale A; Oak S; Kalkar P; Wani H; Patil R; Nair S; Rane P; Teni T
Br J Cancer; 2021 Aug; 125(4):547-560. PubMed ID: 34079080
[TBL] [Abstract][Full Text] [Related]
18. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
[TBL] [Abstract][Full Text] [Related]
20. EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability.
Fu J; Menzies K; Freeman RS; Taubman MB
J Biol Chem; 2007 Apr; 282(17):12410-8. PubMed ID: 17344222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
